Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Lei Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9380-9559; OpenAlex author ID A5053045844. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
23
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 7

  1. Correction: Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoperable pancreatic cancer patients. Co-author DOI 10.1007/s00330-025-12025-x↗
  2. Cell-free DNA testing for the detection and prognosis prediction of pancreatic cancer. Last author DOI 10.1038/s41467-025-61890-z↗
  3. Inhibition Effect of Pancreatic Exocrine Insufficiency on Immune Checkpoint Inhibitor Treatment in Pancreatic Cancer: A Retrospective Study. Co-author DOI 10.2147/itt.s442247↗
  4. Nomogram for predicting survival in patients with pancreatic cancer. Last author DOI 10.2147/ott.s154599↗
  5. Retraction Note: Meta-analysis of the efficacy of pancreatoduodenectomy with extended lymphadenectomy in the treatment of pancreatic cancer. Last author DOI 10.1186/s12957-015-0547-0↗
  6. Meta-analysis of the efficacy of pancreatoduodenectomy with extended lymphadenectomy in the treatment of pancreatic cancer. Last author DOI 10.1186/1477-7819-11-311↗
  7. CEA promoter-regulated oncolytic adenovirus-mediated Hsp70 expression in immune gene therapy for pancreatic cancer. Co-author DOI 10.1016/j.canlet.2012.01.009↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tiansong Xie · 1 shared paper, 2026 · strength 0.32
  2. Yi Chen · 1 shared paper, 2026 · strength 0.32
  3. Wei Liu · 1 shared paper, 2026 · strength 0.32
  4. Zhengrong Zhou · 1 shared paper, 2026 · strength 0.32
  5. Zehua Zhang · 1 shared paper, 2026 · strength 0.32
  6. Tao Qin · 1 shared paper, 2024 · strength 0.22
  7. Qiankun Luo · 1 shared paper, 2024 · strength 0.22
  8. Pan Liu · 1 shared paper, 2024 · strength 0.22
  9. Yin Wang · 1 shared paper, 2025 · strength 0.19
  10. Xiongfei Xu · 1 shared paper, 2025 · strength 0.19
  11. Jianmin Wu · 1 shared paper, 2025 · strength 0.19
  12. Shiwei Guo · 1 shared paper, 2025 · strength 0.19
  13. Gang Jin · 1 shared paper, 2025 · strength 0.19
  14. Dong-liu Miao · 1 shared paper, 2018 · strength 0.14
  15. Wei Song · 1 shared paper, 2018 · strength 0.14
  16. Xinbao Xu · 2 shared papers, 2013–2015 · strength 0.12
  17. Hui Zhang · 2 shared papers, 2013–2015 · strength 0.12
  18. Yunliang Sun · 1 shared paper, 2012 · strength 0.03
  19. Can Xu · 1 shared paper, 2012 · strength 0.03
  20. Zhao‐Shen Li · 1 shared paper, 2012 · strength 0.03
  21. Changqing Su · 1 shared paper, 2012 · strength 0.03
  22. Yan Yan · 1 shared paper, 2012 · strength 0.03
  23. Maoling Zhu · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.